Itafos (CVE:IFOS) Trading Down 5.4% - Here's What Happened

Key Points

• Itafos shares fell 5.4% to C$2.95 on Tuesday, with about 248,419 shares traded—roughly 4% above the average daily volume.
• The stock has a 50‑day moving average of C$3.59 and a 200‑day moving average of C$3.27, and the company sports a market cap of C$572.94 million with a P/E of 7.02.
• Itafos is a phosphate and specialty fertilizer producer with operating and development projects in Brazil and Guinea‑Bissau, including Farim, Araxá, Arraias and Santana.

Itafos Inc. (CVE:IFOS - ) shares were down 5.4% during trading on Tuesday . The company traded as low as C$2.95 and last traded at C$2.95. Approximately 248,419 shares were traded during mid-day trading, an increase of 4% from the average daily volume of 239,993 shares. The stock had previously closed at C$3.12.

Itafos Trading Down 5.4%

The stock has a 50 day moving average of C$3.59 and a 200 day moving average of C$3.27. The firm has a market cap of C$572.94 million, a P/E ratio of 7.02 and a beta of 0.34. The company has a debt-to-equity ratio of 19.58, a current ratio of 2.71 and a quick ratio of 0.73.

Itafos Company Profile

Itafos Inc operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.